CI
72
2
WY
47
-3
PFE
33
3
ACN
29
-2
MSFT
48
-3
VIX
57
7
NWS
62
-2
FTI
69
-2
FRT
48
-2
PRGO
46
-5
HSIC
57
-2
VTR
58
-2
KIM
58
4
AIZ
80
-2
MOS
50
2
L
58
2
MTCH
46
-5
SYK
46
4
EFX
77
16
MPC
44
-2
CI
72
2
WY
47
-3
PFE
33
3
ACN
29
-2
MSFT
48
-3
VIX
57
7
NWS
62
-2
FTI
69
-2
FRT
48
-2
PRGO
46
-5
HSIC
57
-2
VTR
58
-2
KIM
58
4
AIZ
80
-2
MOS
50
2
L
58
2
MTCH
46
-5
SYK
46
4
EFX
77
16
MPC
44
-2
Financhill
Back

National Australia Bank Vs. Monopar Therapeutics Industry Stock Comparison

Sell
23

NABZY
National Australia Bank

Last Price:
$10.32
Seasonality Move:
-0.49%
Sell
45

MNPR
Monopar Therapeutics

Last Price:
$39.96
Seasonality Move:
-24.75%
Sell
23
National Australia Bank (NABZY) is a Sell

Is National Australia Bank a Buy, Sell or Hold?

  • The current National Australia Bank [NABZY] share price is $10.25. The Score for NABZY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NABZY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NABZY Stock Price Chart

What is National Australia Bank's stock price today?

  • The National Australia Bank share price today is $10.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NABZY is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $34.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NABZY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 31.39 Sell
Chaikin Money Flow: -111913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.43 - 12.37) Sell
Bollinger Bands (100): (11.34 - 12.98) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 50.93 Buy
Chaikin Money Flow: 16181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.38 - 44.94) Sell
Bollinger Bands (100): (16.76 - 38.26) Buy

NABZY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.55 Sell
20-day SMA: 11.03 Sell
50-day SMA: 11.74 Sell
200-day SMA: 12.25 Sell
8-day EMA: 10.56 Sell
20-day EMA: 10.99 Sell
50-day EMA: 11.56 Sell
200-day EMA: 11.9 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.92 Buy
20-day SMA: 34.11 Buy
50-day SMA: 35.31 Sell
200-day SMA: 15.6 Buy
8-day EMA: 32.1 Buy
20-day EMA: 33.86 Buy
50-day EMA: 33.39 Buy
200-day EMA: 20.23 Buy

National Australia Bank Earnings Growth & NABZY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.00 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

National Australia Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):